Form 4 Filing: Stock Option Grant to Chief Scientific Officer at Camp4 Therapeutics Corp

Daniel Tardiff, Chief Scientific Officer at Camp4 Therapeutics Corp (CAMP), was granted 170,000 stock options on April 1, 2026. These options, with a right to buy, are exercisable at $4.46 per share and expire on March 31, 2036. The options vest in equal monthly installments over four years, commencing from the date of grant. Mr. Tardiff will directly own 170,000 shares post-transaction. The filing was signed on April 3, 2026.